These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 11844800)

  • 1. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73.
    Stiewe T; Stanelle J; Theseling CC; Pollmeier B; Beitzinger M; Pützer BM
    J Biol Chem; 2003 Apr; 278(16):14230-6. PubMed ID: 12584188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactivation-deficient DeltaTA-p73 acts as an oncogene.
    Stiewe T; Zimmermann S; Frilling A; Esche H; Pützer BM
    Cancer Res; 2002 Jul; 62(13):3598-602. PubMed ID: 12097259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
    Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
    J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
    Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
    J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
    Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
    J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
    Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
    Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.
    Huqun ; Endo Y; Xin H; Takahashi M; Nukiwa T; Hagiwara K
    Cancer Sci; 2003 Aug; 94(8):718-24. PubMed ID: 12901798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relief of p53-mediated telomerase suppression by p73.
    Toh WH; Kyo S; Sabapathy K
    J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
    Zaika AI; Kovalev S; Marchenko ND; Moll UM
    Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression.
    Tuve S; Wagner SN; Schittek B; Pützer BM
    Int J Cancer; 2004 Jan; 108(1):162-6. PubMed ID: 14618632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
    Vikhanskaya F; D'Incalci M; Broggini M
    Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation.
    Fontemaggi G; Gurtner A; Strano S; Higashi Y; Sacchi A; Piaggio G; Blandino G
    Mol Cell Biol; 2001 Dec; 21(24):8461-70. PubMed ID: 11713281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
    Petrenko O; Zaika A; Moll UM
    Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
    Racek T; Mise N; Li Z; Stoll A; Pützer BM
    J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.